FDA Approves Blood Test Which May Let Some Cancer Patients Avoid Additional Biopsies

Published Aug 29, 2020

FDA Approves Blood Test Which May Let Some Cancer Patients Avoid Additional Biopsies

Foundation Medicine just got the green light from the Food and Drug Administration (FDA) to launch a new blood test which could eliminate the fuss of additional biopsies and determine treatment faster.

NOW
PLAYING
As the Government Goes After Google for Antitrust Violations, What Does it Mean For Cancer Patients Who Need Reliable Information?
NOW
PLAYING
What Is a Monoclonal Antibody? Already a Cancer Treatment, Trump Got it for COVID-19
NOW
PLAYING
If You Have Cancer It's More Important Than Ever to Get Flu Shot Amid COVID-19
NOW
PLAYING
$21 Billion Bet On Cancer Drug Trodelvy: What Does It Mean for Patients?
NOW
PLAYING
Woman With Cancer Says Putting Off Care Over COVID Fears Was Grave Mistake
NOW
PLAYING
The 'Right to Try' Act Explained: Cancer Survivor at the RNC Says She’s Alive Thanks to It
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.